Risks in the Drug Procurement System: Current Issues

The public procurement segment is one of the components of the pharmaceutical market in Russia. Procurement of medicines and medical devices is the top sector of public procurement, both in terms of their number and the amount of contracts concluded. The procedure for concluding state contracts itse...

Full description

Saved in:
Bibliographic Details
Published inPropósitos y representaciones Vol. 9; no. SPE3; pp. 1 - 6
Main Authors PRODANOVA, Natalia Alekseevna, ZHAUBATYROV, Usman Salmanovich, ZATSARINNAYA, Elena Ivanovna, GONCHAROV, Vitaly V., ELIZAROVA, Nadezda Sergeevna, BURYAKOV, Stepan Anatol'evich
Format Journal Article
LanguageEnglish
Published Lima Universidad San Ignacio de Loyola S.A 01.05.2021
Subjects
Antitrust
Auctions
Bids
Cartels
Collusion
Contractors
Medical equipment
Pharmaceutical industry
Russia
Online AccessGet full text

Cover

More Information
Summary:The public procurement segment is one of the components of the pharmaceutical market in Russia. Procurement of medicines and medical devices is the top sector of public procurement, both in terms of their number and the amount of contracts concluded. The procedure for concluding state contracts itself is spelled out in sufficient detail in the regulatory documents, but, despite this, risks may arise when concluding a state contract both for a potential applicant for a state order and for a state customer. The purpose of the study is to determine the possible risks when concluding a state contract of a healthcare institution for medicines and medical devices and ways to reduce them.
ISSN:2307-7999
2310-4635
DOI:10.20511/pyr2021.v9nSPE3.1144